Expression of BCR\\ABL fusion transcript and its product protien p210 , in cells derived from patients of chronic myeloid leukemia (CML) , de novo and after treatment /
Hisham Abdelaziz Morsi
Expression of BCR\\ABL fusion transcript and its product protien p210 , in cells derived from patients of chronic myeloid leukemia (CML) , de novo and after treatment / وجود جين ال ب س ر و البروتين الناتج عنة فى خلايا دم مرضى سرطان الدم الميلودى المزمن فى الحالات الجديدة و بعد العلاج Hisham Abdelaziz Morsi ; Supervised Magda M.Assem , Nayera H.Elshakankiry , Sonya F.Arsanyos , Nahla A.Bahgat - Cairo : Hisham Abdelaziz Morsi , 2007 - 129P. : ill ; 25cm
Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department Of Clinical Pathology
One important goal in CML is to monitor the level of BCR - ABL fusion gene and their activity during treatment molecular analysis can be performed on blood samples and are therfore much easier to than cytogenetic analysis of marrow cell metaphases
Chronic Myeloid leukemia (CML) Expression of BCR\\ABL
Expression of BCR\\ABL fusion transcript and its product protien p210 , in cells derived from patients of chronic myeloid leukemia (CML) , de novo and after treatment / وجود جين ال ب س ر و البروتين الناتج عنة فى خلايا دم مرضى سرطان الدم الميلودى المزمن فى الحالات الجديدة و بعد العلاج Hisham Abdelaziz Morsi ; Supervised Magda M.Assem , Nayera H.Elshakankiry , Sonya F.Arsanyos , Nahla A.Bahgat - Cairo : Hisham Abdelaziz Morsi , 2007 - 129P. : ill ; 25cm
Thesis (Ph.D.) - Cairo University - National Cancer Institute - Department Of Clinical Pathology
One important goal in CML is to monitor the level of BCR - ABL fusion gene and their activity during treatment molecular analysis can be performed on blood samples and are therfore much easier to than cytogenetic analysis of marrow cell metaphases
Chronic Myeloid leukemia (CML) Expression of BCR\\ABL